Par Drugs and Chemicals Limited (NSE:PAR)
India · Delayed Price · Currency is INR 80.54
-6.10 (-7.04%)
At close: Mar 27, 2026
Par Drugs and Chemicals Market Cap
Par Drugs and Chemicals has a market cap or net worth of 991.02 million as of March 27, 2026. Its market cap has decreased by -17.46% in one year.
Market Cap
991.02M
Enterprise Value
652.46M
Revenue
1.06B
Ranking
n/a
PE Ratio
7.12
Stock Price
80.54
Market Cap Chart
Since May 16, 2019, Par Drugs and Chemicals's market cap has increased from 310.38M to 991.02M, an increase of 219.29%. That is a compound annual growth rate of 18.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 991.02M | -20.46% |
| Dec 31, 2025 | 1.25B | -49.09% |
| Dec 31, 2024 | 2.45B | -7.79% |
| Dec 29, 2023 | 2.65B | 42.80% |
| Dec 30, 2022 | 1.86B | -24.94% |
| Dec 31, 2021 | 2.48B | 451.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 11.98B |
| Sakar Healthcare | 11.94B |
| Sigachi Industries | 6.96B |
| Valiant Laboratories | 3.09B |
| Bafna Pharmaceuticals | 2.70B |
| Nectar Lifesciences | 1.90B |
| Brooks Laboratories | 1.27B |
| Alpa Laboratories | 1.19B |